Tc Biopharm Holdings Stock Market Value
| TCBP Stock | USD 0.64 0.02 3.03% |
| Symbol | TCBP |
TC BioPharm Holdings Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TC BioPharm. If investors know TCBP will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TC BioPharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.87) | Earnings Share (192.95) | Revenue Per Share 29.639 | Quarterly Revenue Growth 1.886 | Return On Assets (1.09) |
The market value of TC BioPharm Holdings is measured differently than its book value, which is the value of TCBP that is recorded on the company's balance sheet. Investors also form their own opinion of TC BioPharm's value that differs from its market value or its book value, called intrinsic value, which is TC BioPharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TC BioPharm's market value can be influenced by many factors that don't directly affect TC BioPharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TC BioPharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if TC BioPharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TC BioPharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
TC BioPharm 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to TC BioPharm's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of TC BioPharm.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in TC BioPharm on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding TC BioPharm Holdings or generate 0.0% return on investment in TC BioPharm over 30 days. TC BioPharm is related to or competes with Eliem Therapeutics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. TC Biopharm Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its a... More
TC BioPharm Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure TC BioPharm's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess TC BioPharm Holdings upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 85.84 | |||
| Value At Risk | (23.19) | |||
| Potential Upside | 16.08 |
TC BioPharm Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for TC BioPharm's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as TC BioPharm's standard deviation. In reality, there are many statistical measures that can use TC BioPharm historical prices to predict the future TC BioPharm's volatility.| Risk Adjusted Performance | (0.1) | |||
| Jensen Alpha | (1.88) | |||
| Total Risk Alpha | (3.83) | |||
| Treynor Ratio | (3.92) |
TC BioPharm Holdings Backtested Returns
TC BioPharm Holdings retains Efficiency (Sharpe Ratio) of -0.15, which indicates the company had a -0.15% return per unit of price deviation over the last 3 months. TC BioPharm exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate TC BioPharm's information ratio of (0.15), and Market Risk Adjusted Performance of (3.91) to confirm the risk estimate we provide. The firm owns a Beta (Systematic Risk) of 0.46, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, TC BioPharm's returns are expected to increase less than the market. However, during the bear market, the loss of holding TC BioPharm is expected to be smaller as well. At this point, TC BioPharm Holdings has a negative expected return of -1.9%. Please make sure to validate TC BioPharm's information ratio, as well as the relationship between the potential upside and rate of daily change , to decide if TC BioPharm Holdings performance from the past will be repeated sooner or later.
Auto-correlation | 0.82 |
Very good predictability
TC BioPharm Holdings has very good predictability. Overlapping area represents the amount of predictability between TC BioPharm time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of TC BioPharm Holdings price movement. The serial correlation of 0.82 indicates that around 82.0% of current TC BioPharm price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.82 | |
| Spearman Rank Test | 0.48 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
TC BioPharm Holdings lagged returns against current returns
Autocorrelation, which is TC BioPharm stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting TC BioPharm's stock expected returns. We can calculate the autocorrelation of TC BioPharm returns to help us make a trade decision. For example, suppose you find that TC BioPharm has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
TC BioPharm regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If TC BioPharm stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if TC BioPharm stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in TC BioPharm stock over time.
Current vs Lagged Prices |
| Timeline |
TC BioPharm Lagged Returns
When evaluating TC BioPharm's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of TC BioPharm stock have on its future price. TC BioPharm autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, TC BioPharm autocorrelation shows the relationship between TC BioPharm stock current value and its past values and can show if there is a momentum factor associated with investing in TC BioPharm Holdings.
Regressed Prices |
| Timeline |
Pair Trading with TC BioPharm
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if TC BioPharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will appreciate offsetting losses from the drop in the long position's value.Moving together with TCBP Stock
| 0.67 | A | Agilent Technologies Sell-off Trend | PairCorr |
| 0.85 | ME | 23Andme Holding | PairCorr |
| 0.76 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
Moving against TCBP Stock
| 0.67 | MDGL | Madrigal Pharmaceuticals | PairCorr |
| 0.46 | KZR | Kezar Life Sciences | PairCorr |
| 0.41 | MLYS | Mineralys Therapeutics, | PairCorr |
| 0.37 | KEP | Korea Electric Power | PairCorr |
The ability to find closely correlated positions to TC BioPharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace TC BioPharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back TC BioPharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling TC BioPharm Holdings to buy it.
The correlation of TC BioPharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as TC BioPharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if TC BioPharm Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for TC BioPharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for TCBP Stock Analysis
When running TC BioPharm's price analysis, check to measure TC BioPharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TC BioPharm is operating at the current time. Most of TC BioPharm's value examination focuses on studying past and present price action to predict the probability of TC BioPharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TC BioPharm's price. Additionally, you may evaluate how the addition of TC BioPharm to your portfolios can decrease your overall portfolio volatility.